Pioglitazone (Actos) News, Updated Regularly

Diabetes: Pioglitazone and Rosiglitazone may be related to fracture ... - Xagena Medical News
November 18, 2008, 7:11 am

A widely used class of diabetes medications appears to be associated with an increased risk for fractures. ? The insulin-sensitizing thiazolidinediones are a relatively new and effective class of oral antidiabetic agents that have gained wide use ...

Local lab claims success in diabetes treatment, aims to make next ... - MLive.com
November 16, 2008, 11:10 am

Press Photo/Rex Larsen Seeing how it works: Dark spots on X-ray film in the line next to the number 16 show the specific molecules in human cells that the drug mitoglitazone acts on. Numbers at the very top have been blurred to protect proprietary ...

Digital Doctors Connect to Patients, Info Online - MarketingVOX
November 14, 2008, 6:26 am

The number of physicians who use the internet and other digital technologies to access pharmaceutical, biotech, and medical-device information has jumped 20% since 2004 and accounts for 84% of the total US physician population, according to the ...

Study: Diabetes drug fails to slow artery buildup - San Francisco Gate
November 12, 2008, 11:51 am

The controversial diabetes pill Avandia failed to significantly slow plaque buildup in heart arteries compared with an older drug, though there were some hopeful signs in a new study reported Wednesday. Avandia, once a blockbuster drug made by ...

Diabetes drug Avandia fails to slow artery build-up - CNN
November 11, 2008, 3:55 pm

NEW ORLEANS, Louisiana (AP) -- The controversial diabetes pill Avandia failed to significantly slow plaque buildup in heart arteries compared with an older drug, though there were some hopeful signs in a new study reported Wednesday. Patients in the ...

New diabetes rate up 90 percent in past decade - Reuters
October 30, 2008, 10:29 am

WASHINGTON (Reuters) - The rate of new cases of diabetes soared by about 90 percent in the United States in the past decade, fueled by growing obesity and sedentary lifestyles, U.S. health officials said on Thursday. Diabetes experts said the ...

Costly Diabetes Drugs?Are They Worth It? - US News and World Report
October 28, 2008, 5:55 pm

How fitting that in these cost-conscious times, some experts are questioning whether pricey new diabetes drugs like Actos and Byetta actually provide more bang for the buck than older, cheaper ones. Their research dovetails nicely with new diabetes ...

More R&D: Not Boosting Big Pharma - BusinessWeek
October 28, 2008, 5:55 pm

Drug industry R&D spending, by U.S. members of PhRMA, an industry trade group, expanded 20% from 2004 through 2007. Yet the number of Food & Drug Administration-approved new molecular entities and novel biologics declined from 36 to 18 over the same ...

Entries for October 2008 - US News and World Report
October 28, 2008, 5:55 pm

How fitting that in these cost-conscious times, some experts are questioning whether pricey new diabetes drugs like Actos and Byetta actually provide more bang for the buck than older, cheaper ones. Their research dovetails nicely with new diabetes ...

Are you looking for additional Actos (Pioglitazone) news? Try our new "Pioglitazone News Focus" area.

Are you looking for additional Actos (Pioglitazone) information? Try our new "Pioglitazone Related Blog Entries" area.

Off-site Pioglitazone (Actos) Links, User Submitted

The following links have been collected through user bookmark submission in the Pioglitazone_Actos category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Fri Aug 1

• Cardiovascular safety determines the direction of PPAR agonist R&D: The field of novel PPAR delta and of triple (or pan-) PPAR agonists is lead by GSK.

Mon Mar 3

• Pioglitazone (oral) - Yahoo! Health: What is pioglitazone? Pioglitazone is an antihyperglyce mic agent. It helps the... by the liver. It can help control blood sugar levels. Pioglitazone is used, along with diet and exe
• Pioglitazone - Wikipedia, the free encyclopedia: Pioglitazone is a prescription drug of the class thiazolidinedi one with hypoglycemic (antihyperglyc emic, antidiabetic) action. Pioglitazone is marketed as trademarks Actos in the USA and Glustin in Europe by the pharmaceutical company Takeda.
• MedlinePlus Drug Information: Pioglitazone: Pioglitazone is used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). Pioglitazone is
• Actos Consumer Information: What are some possible side effects of Actos? (This list is not a complete list of side effects reported with Actos. Your health care provider can discuss with you a more complete list of side effects.) * cough or cold * headache
• Pioglitazone and Glimepiride (Oral Route) - MayoClinic.com: Pioglitazone and glimepiride combination is used to treat high blood sugar levels that are caused by a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It is used together with proper diet and exercise to help control your blood

Fri Sep 14

• Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Trials

Wed Aug 15

• adverse effects diabetes medications cause heart failure

Mon Dec 4

• 20061124_0456 on Flickr - Photo Sharing!
• 20061108_0306 on Flickr - Photo Sharing!
• 20061124_0457 on Flickr - Photo Sharing!
• Flickr: Photos from Uncle Beast
• 20061124_0463 on Flickr - Photo Sharing!
• 2-deoxyglucose ketogenic diet PEPCK and epilepsy

Tue Nov 28

• Glyceroneogene sis and fatty acid cycling

Off-site Pioglitazone Research Links

If you still need additional information on Pioglitazone then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.